Biodesix, Inc., a data-driven diagnostic solutions company with a focus in lung disease, obtained a term loan facility for up to $50 million from Perceptive Advisors. This debt capital, which is conditioned on the Company raising at least $30 million...
Read Story
November 21, 2022, 07:40 AM
|
Biodesix Inc., a fully integrated molecular diagnostic company dedicated to personalizing medicine, announced that the company closed a structured debt financing with Capital Royalty Partners L.P. The transaction provides Biodesix with up to $20...
Read Story
January 13, 2014, 06:55 AM
|